Skip to main content
. 2017 Nov 15;12:33. doi: 10.1186/s13020-017-0154-9

Fig. 5.

Fig. 5

Inhibitory effects of HS7 on the AKT-mTOR signaling pathway and its downstream effectors in CL1-0 lung cancer cells after 72 h of treatment. a HS7 decreased the protein levels of phosphorylated AKT (p-AKT) and phosphorylated mTOR (p-mTOR) in a dose-dependent manner. b HS7 dose-dependently decreased the phosphorylated p70S6K protein (p-p70S6K). c HS7 dose-dependently decreased the HIF-1α protein. Cell lysates were analyzed by Western blot, using tubulin as loading control